制造PLGA-奇托桑-特兰胺酸复合海绵及其快速血液静止的机制
Yue Zhu1, Teng Chen1, Xiujuan Wan1
1College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
International journal of biological macromolecules
|May 18, 2025
概括
一种新的多 (乳酸-co-糖醇酸) - 奇托桑-特兰克萨姆酸 (PLGA-CTS-TXA) 海绵可为创伤提供快速的血液静止. 这种先进的静血显著减少出血时间,并提高凝固效率.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 血液静止研究 血液静止研究
背景情况:
- 持续的手术内出血是创伤死亡的主要原因.
- 需要先进的血液静止带,提高疗效.
- 基托基材料显示有前途,但需要进一步优化血液静止.
研究的目的:
- 设计和制造一种新的PLGA-CTS-TXA复合海绵,用于快速止血.
- 为了评估复合海绵的静血疗效和生物相容性.
- 为了阐明PLGA-CTS-TXA海绵的静血机制.
主要方法:
- 通过移植制造一个PLGA-CTS-TXA复合海绵.
- 物理性质的评估:孔隙性和吸水性.
- 在体外和体内 (老鼠尾巴和小鼠肝脏模型) 评估生物相容性 (血液溶解,红细胞体积) 和静血性能 (凝血时间).
- 分析物质-生物流体界面及其对凝血的影响.
主要成果:
- PLGA-CTS-TXA海绵表现出高孔隙度 (~85%) 和快速吸水.
- 具有良好的生物相容性,低血解率 (<1.2%) 和良好的红细胞体积 (RCV>125%).
- 与单独使用奇托相比,在老鼠尾巴和小鼠肝脏模型中显著减少了静血时间,其中TXA的纳入是关键.
- 静血机制涉及红细胞/血小板聚合和纤维素降解的调节,影响凝血级联.
结论:
- PLGA-CTS-TXA复合海绵是一种高效的止血,用于快速控制出血.
- 该材料由于PLGA,CTS和TXA的协同作用而表现出卓越的静血能力.
- 这项研究提供了关于新型血液静止剂及其作用机制的发展的见解.
相关概念视频
Introduction to Hemostasis
4.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.6K
Formation of the Platelet Plug
3.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.4K
Extrinsic and Intrinsic Pathways of Hemostasis
4.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.3K
Clot Retraction and Fibrinolysis
3.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.0K
Coagulation
3.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.8K


